X H Liu1, A Aigner, A Wellstein, P E Ray. 1. Children's Research Institute, Research Center for Molecular Physiology, Children's National Medical Center, Washington DC 20010, USA.
Abstract
BACKGROUND: Basic fibroblast growth factor (bFGF) is an angiogenic growth factor that is involved in renal growth and the pathogenesis of renal diseases. We have detected high levels of bFGF accumulated in the kidney of HIV-transgenic mice and in children with HIV-associated renal diseases and the hemolytic uremic syndrome (HUS). However, the mechanism modulating the activity of bFGF under these circumstances is poorly understood. We carried out experiments to determine whether a secreted binding protein (FGF-BP) that modulates the activity of bFGF during the process of tumor growth was expressed in pediatric kidneys and to define whether the expression of FGF-BP was altered in pediatric renal diseases associated with high levels of bFGF. METHODS: Immunohistochemistry and in situ hybridization studies were done in 41 renal sections from children with HIV nephropathies, HUS, other pediatric renal diseases, controls, and fetal kidneys. Western blots and reverse transcriptase-polymerase chain reaction studies were done in selected urine samples and cultured renal cells. Recombinant FGF-BP was produced to study the mitogenic activity of FGF-BP in cultured human renal proximal tubular epithelial cells (RPTEcs). RESULTS: The expression of FGF-BP was up-regulated predominately in renal tubular epithelial cells in children with renal tubular injury, HIV-associated nephropathy (HIVAN), and HUS, and FGF-BP was secreted in the urine of these patients. FGF-BP was also abundantly expressed in developing fetal renal tubules. Recombinant FGF-BP enhanced the mitogenic effects of bFGF in cultured human RPTEcs. CONCLUSIONS: The localization of FGF-BP in renal tubular epithelial cells could provide a mechanism by which the activity of bFGF is modulated in developing and regenerating renal tubules of children.
BACKGROUND:Basic fibroblast growth factor (bFGF) is an angiogenic growth factor that is involved in renal growth and the pathogenesis of renal diseases. We have detected high levels of bFGF accumulated in the kidney of HIV-transgenic mice and in children with HIV-associated renal diseases and the hemolytic uremic syndrome (HUS). However, the mechanism modulating the activity of bFGF under these circumstances is poorly understood. We carried out experiments to determine whether a secreted binding protein (FGF-BP) that modulates the activity of bFGF during the process of tumor growth was expressed in pediatric kidneys and to define whether the expression of FGF-BP was altered in pediatric renal diseases associated with high levels of bFGF. METHODS: Immunohistochemistry and in situ hybridization studies were done in 41 renal sections from children with HIV nephropathies, HUS, other pediatric renal diseases, controls, and fetal kidneys. Western blots and reverse transcriptase-polymerase chain reaction studies were done in selected urine samples and cultured renal cells. Recombinant FGF-BP was produced to study the mitogenic activity of FGF-BP in cultured human renal proximal tubular epithelial cells (RPTEcs). RESULTS: The expression of FGF-BP was up-regulated predominately in renal tubular epithelial cells in children with renal tubular injury, HIV-associated nephropathy (HIVAN), and HUS, and FGF-BP was secreted in the urine of these patients. FGF-BP was also abundantly expressed in developing fetal renal tubules. Recombinant FGF-BP enhanced the mitogenic effects of bFGF in cultured human RPTEcs. CONCLUSIONS: The localization of FGF-BP in renal tubular epithelial cells could provide a mechanism by which the activity of bFGF is modulated in developing and regenerating renal tubules of children.
Authors: Elena Tassi; Kevin McDonnell; Krissa A Gibby; Jason U Tilan; Sung E Kim; David P Kodack; Marcel O Schmidt; Ghada M Sharif; Christopher S Wilcox; William J Welch; G Ian Gallicano; Michael D Johnson; Anna T Riegel; Anton Wellstein Journal: Am J Pathol Date: 2011-09-21 Impact factor: 4.307
Authors: Maciej Tomaszewski; Fadi J Charchar; Christopher P Nelson; Timothy Barnes; Matthew Denniff; Michael Kaiser; Radoslaw Debiec; Paraskevi Christofidou; Suzanne Rafelt; Pim van der Harst; William Y S Wang; Christine Maric; Ewa Zukowska-Szczechowska; Nilesh J Samani Journal: J Am Soc Nephrol Date: 2011-03-24 Impact factor: 10.121
Authors: Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray Journal: Proteomics Clin Appl Date: 2015-06 Impact factor: 3.494
Authors: Corina Gonzalez; G Ariceta; C B Langman; P Zibaoui; L Escalona; L F Dominguez; M A Rosas Journal: Eur J Pediatr Date: 2007-06-26 Impact factor: 3.183
Authors: Andreas Kurtz; Achim Aigner; Rafael H Cabal-Manzano; Robert E Butler; Dozier R Hood; Roy B Sessions; Frank Czubayko; Anton Wellstein Journal: Neoplasia Date: 2004 Sep-Oct Impact factor: 5.715
Authors: Suma Bhat Hoffman; An N Massaro; Angel A Soler-García; Sofia Perazzo; Patricio E Ray Journal: Pediatr Nephrol Date: 2013-06-20 Impact factor: 3.714